Abstract
Highly active antiretroviral therapy (HAART) causes a rapid increase of CD4 + T cells counts during the first 3–6 months of treatment and may enhance the development of opportunistic infections (OIs). However, the short- and long-term effects of HAART exposure on the development of incident OIs has not been extensively studied. This nationwide longitudinal study followed up a total of 26,258 people living with HIV/AIDS (PLWHA) to ascertain the short- and long-term effects of HAART on incident OIs. During 150,196 person-years of follow-up, 6,413 (24.4%) PLWHA had new onset of OIs. After adjusting for demographics, comorbidities, and AIDS status, PLWHA who received HAART were more likely to develop OIs than those who did not receive HAART. Considering the short- and long-term effects of HAART on the development of OIs, HAART was found to be a risk factor for developing OIs during the first 90 days of treatment, but a protective factor against OIs after 180 days of HAART use. The risk for the development of active OIs significantly decreased as the duration of HAART increased (P < 0.001). Our study suggests that HAART is a risk factor for developing OIs in the short term, but is a protective factor in the long term.
Highlights
HIV infection causes the depletion of CD4+ T cells and may increase the risk for opportunistic infections (OIs)
As the duration of Highly active antiretroviral therapy (HAART) increased, the risk of developing active OIs decreased (P < 0.001). This longitudinal study showed that people living with HIV/AIDS (PLWHA) who received HAART were more likely to develop OIs than those who did not
A French hospital-based study followed up 1647 HIV-infected patients and found that HAART significantly increased the risk for incident candidiasis within the first 2 months of treatment (AHR 2.6; 95% CI 1.2–5.5) but was not significantly associated with the development of candidiasis after 2 months of HAART use (AHR 0.8; 95% CI 0.3–2.4)[5]
Summary
HIV infection causes the depletion of CD4+ T cells and may increase the risk for opportunistic infections (OIs). OIs have been reported as the major driver of HIV-associated morbidity and mortality, even in the era of highly active antiretroviral therapy (HAART)[2,3]. Www.nature.com/scientificreports long-term effects of HAART on incident OIs, and their results were inconsistent. Two previous studies revealed that PLWHA who received HAART for more than 90 or 180 days were at lower risk for TB7,8, Mycobacterium avium complex infection[7], cryptococcosis[7], candidiasis[7], or cytomegalovirus (CMV) infection[7]. Another study identified no protective effect against candidiasis development in PLWHA after 60 days of HAART5.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
